With an entrepreneurial spirit and a focus on relationship building, Laidlaw & Company UK Ltd. offers financial solutions and personalized investment advice for corporations, institutions, and individuals. Since its founding in 1842, Laidlaw & Company has been serving domestic and international as well as private and public clients with all their investment and securities brokerage needs, with a more recent focus in healthcare and technology. Now with over 150 employees, Laidlaw & Company continues to grow its network of offices across the United States and Europe under CEO Matt Eitner and Managing Partner James Ahern. As a parent company, Laidlaw & Company UK Ltd. holds subsidiaries including Laidlaw Asset Management and Laidlaw Venture Partners.
The company is driven by a team of international professionals with both bulge bracket and boutique firm experience, providing clients with a holistic approach to financial solutions and hands-on transaction management. In recent decades, Laidlaw & Company has looked towards research and banking initiatives in healthcare, biotechnology, pharmaceuticals, and other medical devices, as well as adding metals, mining, and natural resources to their investment banking and capital markets strategy portfolio.
Laidlaw & Company UK Ltd., has offices in New York, Florida, California, and the United Kingdom and is a registered broker-dealer with FINRA in the United States, is authorized by the Financial Conduct Authority (FCA) in the United Kingdom, and is a member of the Securities Investor Protection Corporation (SIPC).